loadpatents
name:-0.034909009933472
name:-0.025646924972534
name:-0.002936840057373
Morre; D. James Patent Filings

Morre; D. James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Morre; D. James.The latest application filed is for "methods and compositions for single chain variable region enox2 antibodies for cancer detection and diagnosis".

Company Profile
2.21.26
  • Morre; D. James - West Lafayette IN
  • MORRE, D. JAMES - LAFAYETTE IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
Grant 10,712,345 - Morre , et al.
2020-07-14
Methods And Compositions For Single Chain Variable Region Enox2 Antibodies For Cancer Detection And Diagnosis
App 20200174001 - Morre; D. James ;   et al.
2020-06-04
Methods and compositions for identification and quantification of ENOX2 transcript variants as indications of cancer presence in blood serum and other body fluids based on gold or silver nanoparticle formation
Grant 9,891,222 - Morre , et al. February 13, 2
2018-02-13
Methods And Compositions For Single Chain Variable Region Enox2 Antibodies For Cancer Detection And Diagnosis
App 20170343555 - Morre; D. James ;   et al.
2017-11-30
Methods and Compositions for Identification and Quantitation of ENOX2 Transcript Variants as Indications of Cancer Presence in Blood Serum and Other Body Fluids Based on Gold or Silver Nanoparticle Formation
App 20170322214 - Morre; D. James ;   et al.
2017-11-09
Methods for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
Grant 9,804,166 - Morre , et al. October 31, 2
2017-10-31
Methods and compositions for targeted two-dimensional western blot analysis for early cancer detection and cancer diagnosis up to ten years in advance of clinical symptoms of malignant disease
Grant 9,804,165 - Morre October 31, 2
2017-10-31
Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
Grant 9,739,782 - Morre , et al. August 22, 2
2017-08-22
Methods and compositions for targeted two-dimensional western blot analysis for early cancer detection and cancer diagnosis up to ten years in advance of clinical symptoms of malignant disease
Grant 9,612,243 - Morre April 4, 2
2017-04-04
Methods For Single Chain Variable Region Enox2 Antibodies For Cancer Detection And Diagnosis
App 20170030918 - Morre; D. James ;   et al.
2017-02-02
Methods And Compositions For Single Chain Variable Region Enox2 Antibodies For Cancer Detection And Diagnosis
App 20170030919 - Morre; D. James ;   et al.
2017-02-02
Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
Grant 9,459,256 - Morre , et al. October 4, 2
2016-10-04
Compositions That Lower Cytosolic NADH Level to Mimic Calorie Restriction for Life Extension and Methods
App 20160271200 - Morre; D. James
2016-09-22
Growth-related Enox Proteins From Plants With Yield Enhancement Potential, Sequences And Methods
App 20160108414 - Morre; D. James ;   et al.
2016-04-21
Compositions comprising solanum tuberosum for lowering cytosolic NADH level to mimic calorie restriction
Grant 9,283,257 - Morre March 15, 2
2016-03-15
Methods And Compositions For Single Chain Variable Region Enox2 Antibodies For Cancer Detection And Diagnosis
App 20140212896 - Morre; D. James ;   et al.
2014-07-31
Aging-related circulating particle-associated lipoprotein B oxidase (apoBNOX) and inhibitors thereof
Grant 8,465,939 - Morre June 18, 2
2013-06-18
Cloning and Expression of arNOX Protein Transmembrane 9 Superfamily (TM9SF), Methods and Utility
App 20120315629 - Morre; D. James ;   et al.
2012-12-13
ORAL INHIBITORS OF AGE-RELATED NADH OXIDASE (arNOX), COMPOSITIONS AND NATURAL SOURCES
App 20120207862 - Morre; D. James ;   et al.
2012-08-16
Neoplasia-Specific Autoantibodies and Methods
App 20120034626 - Morre; D. James ;   et al.
2012-02-09
Aging-Related Circulating Particle-Associated Lipoprotein B Oxidase (apoBNOX) and Inhibitors Thereof
App 20110217401 - Morre; D. James
2011-09-08
Compositions That Lower Cytosolic Nadh Level To Mimic Calorie Restriction For Life Extension And Methods
App 20110111069 - Morre; D. James
2011-05-12
Compositions and methods for treating and preventing virus infections
Grant 7,491,413 - Morre , et al. February 17, 2
2009-02-17
Anticancer Treatment
App 20080095869 - Archibald; David ;   et al.
2008-04-24
Compositions and methods for treating and preventing virus infections
App 20070077316 - Morre; D. James ;   et al.
2007-04-05
Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
Grant 7,192,612 - Morre , et al. March 20, 2
2007-03-20
Neoplasia-specific splice variants and methods
App 20060292577 - Morre; D. James ;   et al.
2006-12-28
Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
Grant 7,053,188 - Morre , et al. May 30, 2
2006-05-30
Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof
App 20050169903 - Morre, Dorothy M. ;   et al.
2005-08-04
Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof
Grant 6,878,514 - April 12, 2
2005-04-12
Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
App 20050031716 - Morre, D. James ;   et al.
2005-02-10
Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer
App 20040142048 - Morre, Dorothy M. ;   et al.
2004-07-22
Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
Grant 6,759,064 - July 6, 2
2004-07-06
Tea catechins as cancer specific proliferation inhibitors
Grant 6,652,890 - Morre , et al. November 25, 2
2003-11-25
Sequences encoding human neoplastic marker
App 20030207340 - Morre, D. James ;   et al.
2003-11-06
Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
App 20030170757 - Morre, D. James ;   et al.
2003-09-11
Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
App 20030158088 - Grieco, Paul A. ;   et al.
2003-08-21
Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
App 20030072821 - Morre, Dorothy M. ;   et al.
2003-04-17
Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
App 20020176898 - Morre, Dorothy M. ;   et al.
2002-11-28
Tea catechins as cancer specific proliferation inhibitors
App 20020176897 - Morre, Dorothy M. ;   et al.
2002-11-28
Tea catechin formulations and processes for making same
Grant 6,428,818 - Morre , et al. August 6, 2
2002-08-06
Therapeutic Quassinoid Preparations With Antineoplastic, Antiviral, And Herbistatic Activity
App 20020019439 - GRIECO, PAUL A. ;   et al.
2002-02-14
Thiol activation of cytotoxic and auxin-herbicidal agents and root formation stimulation
Grant 5,643,853 - Morre July 1, 1
1997-07-01
Capsacinoid compounds as proliferation inhibitors
Grant 5,569,673 - Morre , et al. October 29, 1
1996-10-29
Cancer detection by serum analysis of glycolipids
Grant 4,115,062 - Morre , et al. September 19, 1
1978-09-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed